|
Diabetes Care, Vol 9, Issue 2 189-193, Copyright © 1986 by American Diabetes Association
Evaluation of a new radioimmunoassay for urinary albumin
RG Brodows, D Nichols, G Shaker and NP Kubasik
We have evaluated a new commercially available radioimmunoassay kit for
albumin determination in urine. The assay is precise; within-run precision
(CV) in the clinically significant ranges is 1.8-3.5%, between-run,
1.2-8.5%. The minimum detection limit was 0.6 micrograms/ml. Analytic
recovery of different concentrations of albumin added to urine ranged from
98% to 103%. Samples, stored in plastic containers, were stable at room
temperature for periods up to 7 days. Mean albumin excretion rates,
measured in 20 normal volunteers for 3-h and 24-h periods during the same
day were similar (7.1 +/- 4.6 [SD] versus 6.5 +/- 5.0 micrograms/min). In 8
normal subjects, 3-h excretion rates measured daily for 5 days showed no
significant variability. In eight insulin-dependent diabetic subjects,
albumin excretion measured in short periods of urine collection (3 h) were
also in close agreement with 24-h collections (24.7 +/- 28.9 versus 17.6
+/- 18 micrograms/min). From these results it appears that this
commercially available kit is suitable for conveniently monitoring
microalbuminuria in large numbers of patients in research studies as well
as for office practice. Such widespread use should make it possible to
better determine the clinical usefulness of this test in the management of
diabetic patients.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Narita, M. Hosoba, M. Kakei, and S. Ito
Increased Urinary Excretions of Immunoglobulin G, Ceruloplasmin, and Transferrin Predict Development of Microalbuminuria in Patients With Type 2 Diabetes
Diabetes Care,
January 1, 2006;
29(1):
142 - 144.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Narita, H. Sasaki, M. Hosoba, T. Miura, N. Yoshioka, T. Morii, T. Shimotomai, J. Koshimura, H. Fujita, M. Kakei, et al.
Parallel Increase in Urinary Excretion Rates of Immunoglobulin G, Ceruloplasmin, Transferrin, and Orosomucoid in Normoalbuminuric Type 2 Diabetic Patients
Diabetes Care,
May 1, 2004;
27(5):
1176 - 1181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Berton, R Cordiano, R Palmieri, F Cucchini, R de Toni, and P Palatini
Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality
Eur. Heart J.,
August 2, 2001;
22(16):
1466 - 1475.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Reddi, V. R. Nimmagadda, A. Lefkowitz, H.-R. Kuo, and J. S. Bollineni
Effect of Antihypertensive Therapy on Renal Injury in Type 2 Diabetic Rats With Hypertension
Hypertension,
August 1, 2000;
36(2):
233 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Berton, T. Citro, R. Palmieri, S. Petucco, S. Renzo De Toni, and P. Palatini
Albumin Excretion Rate Increases During Acute Myocardial Infarction and Strongly Predicts Early Mortality
Circulation,
November 18, 1997;
96(10):
3338 - 3345.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. N. Jyothirmayi, I. Alluru, and A. S. Reddi
Doxazosin Prevents Proteinuria and Glomerular Loss of Heparan Sulfate in Diabetic Rats
Hypertension,
May 1, 1996;
27(5):
1108 - 1114.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1986 by the American Diabetes Association.
|
|
| |
|